| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2016 | Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue | Lai C.-Y.; Lee S.-Y.; Scarr E.; Yu Y.-H.; Lin Y.-T.; Liu C.-M.; Hwang T.-J.; Hsieh M.H.; Liu C.-C.; YI-LING CHIEN ; Udawela M.; Gibbons A.S.; Everall I.P.; Hwu H.-G.; Dean B.; Chen W.J. | Translational psychiatry | 32 | 40 | |
| 2016 | Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue | Lai C.-Y.; Lee S.-Y.; Scarr E.; Yu Y.-H.; Lin Y.-T.; Liu C.-M.; TZUNG-JENG HWANG ; Hsieh M.H.; Liu C.-C.; Chien Y.-L.; Udawela M.; Gibbons A.S.; Everall I.P.; Hwu H.-G.; Dean B.; Chen W.J. | Translational psychiatry | 40 | ||
| 2016 | Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue | Lai C.-Y.; Lee S.-Y.; Scarr E.; Yu Y.-H.; YI-TING LIN ; Liu C.-M.; Hwang T.-J.; Hsieh M.H.; Liu C.-C.; Chien Y.-L.; Udawela M.; Gibbons A.S.; Everall I.P.; Hwu H.-G.; Dean B.; Chen W.J. | Translational psychiatry | 40 | ||
| 2016 | Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue | Lai C.-Y.; Lee S.-Y.; Scarr E.; Yu Y.-H.; Lin Y.-T.; Liu C.-M.; Hwang T.-J.; MING-HSIEN HSIEH ; Liu C.-C.; Chien Y.-L.; Udawela M.; Gibbons A.S.; Everall I.P.; Hwu H.-G.; Dean B.; Chen W.J. | Translational psychiatry | 29 | 40 | |
| 2016 | Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue | Lai C.-Y.; Lee S.-Y.; Scarr E.; Yu Y.-H.; Lin Y.-T.; Liu C.-M.; Hwang T.-J.; Hsieh M.H.; CHEN-CHUNG LIU ; Chien Y.-L.; Udawela M.; Gibbons A.S.; Everall I.P.; Hwu H.-G.; Dean B.; Chen W.J. | Translational psychiatry | 40 | ||
| 2016 | Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue | Lai C.-Y.; Lee S.-Y.; Scarr E.; Yu Y.-H.; Lin Y.-T.; CHIH-MIN LIU ; Hwang T.-J.; Hsieh M.H.; Liu C.-C.; Chien Y.-L.; Udawela M.; Gibbons A.S.; Everall I.P.; Hwu H.-G.; Dean B.; Chen W.J. | Translational psychiatry | 40 | ||
| 2016 | Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue | Lai C.-Y.; Lee S.-Y.; Scarr E.; Yu Y.-H.; Lin Y.-T.; Liu C.-M.; Hwang T.-J.; Hsieh M.H.; Liu C.-C.; Chien Y.-L.; Udawela M.; Gibbons A.S.; Everall I.P.; HAI-GWO HWU ; Dean B.; Chen W.J. | Translational psychiatry | 40 | ||
| 2005 | Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma. | Peng S.Y.; Ou Y.H.; Chen W.J.; Li H.Y.; Liu S.H.; Pan H.W.; Lai P.L.; YUNG-MING JENG ; Chen D.C.; Hsu H.C. | International journal of oncology | 25 | 27 | |
| 2020 | Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms? | Jen Y.-W.; Hwang T.-J.; Chan H.-Y.; Hsieh M.H.; Liu C.-C.; Liu C.-M.; Hwu H.-G.; CHING-HUA KUO ; Lin Y.-T.; Chien Y.-L.; Chen W.J. | BMC Psychiatry | 0 | ||
| 2020 | Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms? | Jen Y.-W.; Hwang T.-J.; Chan H.-Y.; Hsieh M.H.; Liu C.-C.; Liu C.-M.; Hwu H.-G.; Kuo C.-H.; YI-TING LIN ; Chien Y.-L.; Chen W.J. | BMC Psychiatry | 0 | ||
| 2020 | Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms? | Jen Y.-W.; TZUNG-JENG HWANG ; Chan H.-Y.; Hsieh M.H.; Liu C.-C.; Liu C.-M.; Hwu H.-G.; Kuo C.-H.; Lin Y.-T.; Chien Y.-L.; Chen W.J. | BMC Psychiatry | 0 | ||
| 2020 | Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms? | Jen Y.-W.; Hwang T.-J.; Chan H.-Y.; Hsieh M.H.; CHEN-CHUNG LIU ; Liu C.-M.; Hwu H.-G.; Kuo C.-H.; Lin Y.-T.; Chien Y.-L.; Chen W.J. | BMC Psychiatry | 0 | ||
| 2020 | Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms? | Jen Y.-W.; Hwang T.-J.; Chan H.-Y.; MING-HSIEN HSIEH ; Liu C.-C.; Liu C.-M.; Hwu H.-G.; Kuo C.-H.; Lin Y.-T.; Chien Y.-L.; Chen W.J. | BMC Psychiatry | 0 | ||
| 2020 | Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms? | Jen Y.-W.; Hwang T.-J.; Chan H.-Y.; Hsieh M.H.; Liu C.-C.; CHIH-MIN LIU ; Hwu H.-G.; Kuo C.-H.; Lin Y.-T.; Chien Y.-L.; Chen W.J. | BMC Psychiatry | 0 | ||
| 2020 | Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms? | Jen Y.-W.; Hwang T.-J.; Chan H.-Y.; Hsieh M.H.; Liu C.-C.; Liu C.-M.; Hwu H.-G.; Kuo C.-H.; Lin Y.-T.; YI-LING CHIEN ; Chen W.J. | BMC Psychiatry | 0 | ||
| 2020 | Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms? | Jen Y.-W.; Hwang T.-J.; Chan H.-Y.; Hsieh M.H.; Liu C.-C.; Liu C.-M.; HAI-GWO HWU ; Kuo C.-H.; Lin Y.-T.; Chien Y.-L.; Chen W.J. | BMC Psychiatry | 0 | ||
| 2006 | Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population | Liu Y.-L.; Fann C.S.-J.; Liu C.-M.; Wu J.-Y.; Hung S.-I.; Chan H.-Y.; Chen J.-J.; Pan C.-C.; Liu S.-K.; MING-HSIEN HSIEH ; Hwang T.-J.; OuYang W.-C.; Chen C.-Y.; Lin J.-J.; Chou F.H.-C.; Chueh C.-M.; Liu W.-M.; Tsuang M.-M.; Faraone S.V.; Tsuang M.T.; Chen W.J.; Hwu H.-G. | Psychiatric Genetics | 31 | 31 | |
| 2006 | Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population | Liu Y.-L.; Fann C.S.-J.; Liu C.-M.; Wu J.-Y.; Hung S.-I.; Chan H.-Y.; Chen J.-J.; Pan C.-C.; Liu S.-K.; Hsieh M.H.; TZUNG-JENG HWANG ; OuYang W.-C.; Chen C.-Y.; Lin J.-J.; Chou F.H.-C.; Chueh C.-M.; Liu W.-M.; Tsuang M.-M.; Faraone S.V.; Tsuang M.T.; Chen W.J.; Hwu H.-G. | Psychiatric Genetics | 31 | ||
| 2007 | Absent response to niacin skin patch is specific to schizophrenia and independent of smoking | Liu C.-M.; Chang S.-S.; Shih-Cheng Liao ; Hwang T.-J.; Shieh M.-H.; Liu S.-K.; Chen W.J.; Hwu H.-G. | Psychiatry Research | 25 | 24 | |
| 2007 | Absent response to niacin skin patch is specific to schizophrenia and independent of smoking | Liu C.-M.; Chang S.-S.; Liao S.-C.; TZUNG-JENG HWANG ; Shieh M.-H.; Liu S.-K.; Chen W.J.; Hwu H.-G. | Psychiatry Research | 24 |
